ZD 6416
Latest Information Update: 07 Feb 2003
At a glance
- Originator AstraZeneca
- Class Analgesics
- Mechanism of Action Prostaglandin E1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neuropathic pain